Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara O'Donohue

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Opinion in Pediatrics|November 15, 2022
Progress in precision therapy in pediatric oncologyTara O'Donohue, Sameer Farouk Sait, Julia Glade Bender
JCO Precision Oncology|July 12, 2021
Differential Impact of <i>ALK</i> Mutations in NeuroblastomaTara O'Donohue, Nitya Gulati, Audrey Mauguen, et al.
Leukemia & Lymphoma|November 30, 2017
Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experienceLisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, et al.
Nature Communications|November 27, 2025
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncologyDylan Domenico, Gunes Gundem, Max F Levine, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcomaMichael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
British Journal of Haematology|October 31, 2017
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-RLisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Opinion in Pediatrics|November 15, 2022
Progress in precision therapy in pediatric oncologyTara O'Donohue, Sameer Farouk Sait, Julia Glade Bender
JCO Precision Oncology|July 12, 2021
Differential Impact of <i>ALK</i> Mutations in NeuroblastomaTara O'Donohue, Nitya Gulati, Audrey Mauguen, et al.
Leukemia & Lymphoma|November 30, 2017
Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experienceLisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, et al.
Nature Communications|November 27, 2025
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncologyDylan Domenico, Gunes Gundem, Max F Levine, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcomaMichael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
British Journal of Haematology|October 31, 2017
Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-RLisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, et al.
Pageof 1